Anonymous v Pfizer: Regional account directors not required to pass ABPI Medical Representatives Examination (AUTH/2374/12/10)

📅 2010 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/2374/12/10
PartiesAnonymous v Pfizer
IssueFailure to sit ABPI Medical Representatives Examination
Complaint received03 December 2010
Case completed03 February 2011
Applicable Code year2008
Breach clauses16.3
AppealNo appeal
SanctionsUndertaking received; Additional sanctions: Not stated
Key Panel findingRAD role met the broad definition of “representative”; calling on prescribers in association with promotion triggered the exam requirement; two RADs had been in post for 2 years without taking the exam.

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • An anonymous complainant alleged Pfizer did not require some regional account directors (RADs) to sit and pass the ABPI Medical Representatives Examination.
  • The complainant said RADs saw NHS customers and discussed brand strategic position, potentially bringing them within the Code’s definition of a “representative”.
  • Pfizer said RADs met senior NHS business managers (eg, strategic health authority chief executives; directors of finance, public health, commissioning or strategy), not prescribers as prescribers, and would not discuss clinical efficacy/safety; they would bring in an appropriate colleague for brand discussions.
  • Pfizer provided exam status for nine RADs: seven had passed (from prior roles); two were recruited from outside pharma and had not taken the exam.
  • The Panel reviewed differing (undated) RAD job descriptions provided by the complainant and Pfizer, noting responsibilities including delivering sales targets through teams, influencing opinion-formers, and requiring negotiation/selling skills.
  • The Panel concluded RADs met the broad definition of “representative” and that calling on prescribers “in association with the promotion of medicines” triggered the exam requirement.
  • Two RADs had been in post for 2 years and had not taken the examination.
⚖️

Outcome

  • Breach found: Clause 16.3.
  • No appeal.
  • Case published in the February 2011 Code of Practice Review.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training